InsiderClue
← All stocks

Olema Pharmaceuticals, Inc.

OLMA Net buying
CIK 0001750284 #2588 in the set updated 20 Sep 2026
Bought (120 mo)
$88.75M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$95.43M
$3.55M on a plan · $22.47M straight out of an exercise
Sold at will
$69.42M
65 of 127 sales
Net
−$6.69M
+$19.33M against sales at will

By person

19 insiders · 162 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BVF PARTNERS L P/IL entity
Director
$44.14M (11)
—
+$44.14M
547,082
0.6253%
$6.41M
—
Paradigm Biocapital Advisors LP entity
10% owner
$1.16M (1)
$35.80M (2)
−$34.64M
783,118
0.8950%
$9.17M
−74.6%
Graham G. Walmsley
Director
$33.64M (6)
$22.18M (3)
+$11.46M
2,568,875
2.94%
$30.09M
+237.3%
Cormorant Asset Management, LP entity
Former 10% Owner
$8.08M (1)
—
+$8.08M
3,270,544
3.74%
$38.31M
—
Zojwalla Naseem
CHIEF MEDICAL OFFICER
—
$7.99M (10) scheduled
−$7.99M
4,488
0.0051%
$52.57K
−80.7%
CLARK IAN T
Director
—
$7.87M (3) scheduled
−$7.87M
0
0.0000%
$0.00
—
Harmon Cyrus
Director
—
$6.37M (50)
−$6.37M
941,826
1.08%
$11.03M
−8.2%
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
—
$5.61M (20) scheduled
−$5.61M
842,453
0.9628%
$9.87M
+38.8%
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
— (2)
$3.57M (8)
−$3.57M
139,727
0.1597%
$1.64M
+644.4%
Horn Kinney
Chief Business Officer
—
$2.98M (16) scheduled
−$2.98M
2,458
0.0028%
$28.79K
0.0%
Bohen Sean
PRESIDENT AND CEO
—
$2.11M (12)
−$2.11M
237,650
0.2716%
$2.78M
+806.1%
Bain Capital Life Sciences Investors, LLC entity
10% owner
$1.73M (1)
—
+$1.73M
4,300,000
4.91%
$50.37M
−42.7%
Mitchell Shawnte
CHIEF LEGAL OFFICER
—
$951.50K (3) scheduled
−$951.50K
0
0.0000%
$0.00
—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
—
—
—
1,725,406
1.97%
$20.21M
—
Kushner Peter J.
CHIEF SCIENTIFIC OFFICER
—
—
—
1,431,672
1.64%
$16.77M
+54.1%
RAPPAPORT ANDREW
Director
—
—
—
866,979
0.9909%
$10.16M
+68.8%
MCCORMICK FRANK
Director
—
—
—
275,373
0.3147%
$3.23M
+390.4%
BUTITTA CYNTHIA M
Director
—
—
—
83,876
0.0959%
$982.52K
—
Austin Sasha Lu
VP of Finance and Controller
—
—
—
16,188
0.0185%
$189.63K
+260.7%

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Harmon Cyrus
30 Jul 2024
Director
Sold on a plan
934
$15.55
$14.52K
Harmon Cyrus
29 Jul 2024
Director
Sold on a plan
4,066
$15.58
$63.35K
Harmon Cyrus
11 Jul 2024
Director
Sold on a plan
5,000
$12.26
$61.30K
Harmon Cyrus
28 Jun 2024
Director
Sold on a plan
20,000
$10.77
$215.40K
Harmon Cyrus
4 Jun 2024
Director
Sold on a plan
5,000
$12.33
$61.65K
Harmon Cyrus
3 Jun 2024
Director
Sold on a plan
5,000
$10.93
$54.65K
Harmon Cyrus
31 May 2024
Director
Sold on a plan
15,000
$9.41
$141.15K
Harmon Cyrus
6 May 2024
Director
Sold on a plan
5,000
$10.92
$54.60K
Harmon Cyrus
30 Apr 2024
Director
Sold on a plan
15,000
$9.51
$142.65K
Harmon Cyrus
28 Mar 2024
Director
Sold on a plan
20,000
$10.97
$219.40K
Harmon Cyrus
29 Feb 2024
Director
Sold on a plan
100
$13.00
$1.30K
Harmon Cyrus
29 Feb 2024
Director
Sold on a plan
24,900
$12.41
$309.01K
Harmon Cyrus
1 Feb 2024
Director
Sold on a plan
5,000
$15.56
$77.80K
Harmon Cyrus
31 Jan 2024
Director
Sold on a plan
25,000
$12.23
$305.75K
Harmon Cyrus
30 Nov 2023
Director
Sold on a plan
25,000
$12.57
$314.25K
Myles David C.
8 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
200
$17.61
$3.52K
Myles David C.
3 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
541
$17.51
$9.47K
Harmon Cyrus
2 Nov 2023
Director
Sold on a plan
5,000
$15.64
$78.20K
Myles David C.
2 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
3,332
$15.36
$51.18K
Myles David C.
1 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
6,668
$15.02
$100.15K
Harmon Cyrus
31 Oct 2023
Director
Sold on a plan
25,000
$12.05
$301.25K
Harmon Cyrus
29 Sep 2023
Director
Sold on a plan
25,000
$12.41
$310.25K
Myles David C.
19 Sep 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
20,000
$12.67
$253.40K
Harmon Cyrus
5 Sep 2023
Director
Sold on a plan
10,000
$11.62
$116.20K
Harmon Cyrus
31 Aug 2023
Director
Sold on a plan
15,000
$9.36
$140.40K
Harmon Cyrus
16 Aug 2023
Director
Sold on a plan
15,000
$10.14
$152.10K
Show all 162 transactions →

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 36
Sales at will 65
Transactions with no price 2
Shares from compensation/vesting 24,931,528
Sales filed before the plan box existed 11
History held since 19 Nov 2020